784
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for osteoporosis

& , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Luigi Gennari & John P. Bilezikian. (2018) New and developing pharmacotherapy for osteoporosis in men. Expert Opinion on Pharmacotherapy 19:3, pages 253-264.
Read now

Articles from other publishers (14)

Xuan Wang, Xintong Liang, Tenghua Wang, Yaoxuan Zhan, Haiyan Liu, Chen Li, Xianbo Li, Hui Ma, Zhiqin Hu, Xiaole Wang, Shuangshuang Xiao, Li Ban, Jin He, Yongmei Li & Yi Fang. (2023) Biosimilarity Assessment of the Biosimilar Teriparatide Candidate and the Reference Drug in Healthy Subjects. Clinical Pharmacology in Drug Development 12:5, pages 518-524.
Crossref
Manon Belhassen, Bernard Cortet, Cyrille B. Confavreux, Liliane Lamezec, Marine Ginoux & Eric Van Ganse. (2018) Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France. Archives of Osteoporosis 13:1.
Crossref
Pedro Lavrador, Vítor M. Gaspar & João F. Mano. (2018) Stimuli-responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses. Journal of Controlled Release 273, pages 51-67.
Crossref
Leanne M. Ward & Jinhui Ma. 2018. Pediatric Endocrinology. Pediatric Endocrinology 525 565 .
Monica Grover & Laura K. Bachrach. 2018. A Practical Approach to Adolescent Bone Health. A Practical Approach to Adolescent Bone Health 243 259 .
Simit Mahesh Doshi, Tom T. Noff & G. David Roodman. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 595 607 .
Monica Grover & Laura K. Bachrach. (2017) Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment. Current Osteoporosis Reports 15:4, pages 271-282.
Crossref
Giovanni Lombardi, Mosè Barbaro, Massimo Locatelli & Giuseppe Banfi. (2017) Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles. Endocrine 56:3, pages 460-484.
Crossref
M. Belhassen, C. B. Confavreux, B. Cortet, L. Lamezec, M. Ginoux & E. Van Ganse. (2016) Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up. Osteoporosis International 28:3, pages 853-862.
Crossref
Roland D. Chapurlat & Cyrille B. Confavreux. (2016) Novel biological markers of bone: from bone metabolism to bone physiology. Rheumatology 55:10, pages 1714-1725.
Crossref
L. M. Ward, V. N. Konji & J. Ma. (2016) The management of osteoporosis in children. Osteoporosis International 27:7, pages 2147-2179.
Crossref
Eric S Muise, Alexei A Podtelezhnikov, Maureen Pickarski, Andrey Loboda, Yejun Tan, Guanghui Hu, John R Thomspon & Le T Duong. (2016) Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate. Journal of Bone and Mineral Research 31:4, pages 839-851.
Crossref
A.L. Boskey. 2016. Handbook of nutrition and diet in therapy of bone diseases. Handbook of nutrition and diet in therapy of bone diseases 277 304 .
Abigail Bertonazzi, Bridgette Nelson, Jamie Salvador & Elena Umland. (2015) The Smallest Available Estradiol Transdermal Patch: A New Treatment Option for the Prevention of Postmenopausal Osteoporosis. Women's Health 11:6, pages 815-824.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.